Renal Outcomes and Factors Predicting the Outcomes after Conversion to Sirolimus from Calcineurin Inhibitors in Chronic Renal Allograft Dysfunction.

被引：0
|
作者：
Swaminathan, Ramyasuda [1 ]
Irish, Ashley [1 ]
机构：
[1] Royal Perth Hosp, Perth, WA, Australia
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2009年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：585 / 585
页数：1
相关论文
共 50 条
  • [21] A randomized, open-label, comparative evaluation of conversion from calcineurin inhibitors to sirolimus versus continued use of calcineurin inhibitors in renal allograft recipients
    Schena, FP
    Wali, RK
    Pascoe, MD
    Alberu, J
    Rial, MD
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 413 - 413
  • [22] Conversion to and from sirolimus in renal and hepatic transplant recipients treated with calcineurin inhibitors: Effect on renal function
    Moneim, HA
    Flechner, SM
    Goel, M
    Derweesh, IH
    Modlin, C
    Krishnamurthi, V
    Goldfarb, DA
    Novick, AC
    JOURNAL OF UROLOGY, 2005, 173 (04): : 419 - 419
  • [23] Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus
    Backman, L
    Reisæter, AV
    Wramner, L
    Ericzon, BG
    Salmela, K
    Brattström, C
    CLINICAL TRANSPLANTATION, 2006, 20 (03) : 336 - 339
  • [24] Long-term results after conversion from calcineurin inhibitors to sirolimus in renal transplant patients
    Martinez-Mier, Gustavo
    Avila-Pardo, Sandro F.
    Mendez-Lopez, Marco T.
    Budar-Fernandez, Luis F.
    CLINICAL TRANSPLANTATION, 2010, 24 (04) : 467 - 473
  • [25] Outcomes of calcineurin inhibitors conversion to mammalian target of rapamycin inhibitors in children with renal transplantation
    Piyaphanee, Nuntawan
    Supavekin, Suroj
    Pattaragarn, Anirut
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1517 - 1518
  • [26] Conversion From Cyclosporine to Sirolimus in Chronic Renal Allograft Dysfunction: A 4-Year Prospective Study
    Han, Fei
    Wu, Jianyong
    Huang, Hongfeng
    Zhang, Xiaohui
    He, Qiang
    Wang, Yimin
    Wang, Suya
    Wang, Huiping
    Chen, Jianghua
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2011, 9 (01) : 42 - 49
  • [27] Sirolimus is effective as a rescue agent in pediatric renal transplant recipients with allograft dysfunction.
    Al-Akash, SI
    Al Makadma, AS
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 66 - 66
  • [28] Sirolimus (rapamycin) as rescue therapy in liver transplant recipients with chronic rejection and calcineurin inhibitor induced renal dysfunction.
    Sultan, S
    Tuttle-Newhall, JE
    Rockey, DC
    Muir, AJ
    Bornstein, JD
    Collins, B
    Kuo, PC
    Heneghan, MA
    HEPATOLOGY, 2002, 36 (04) : 662A - 662A
  • [29] Conversion to Sirolimus for Chronic Allograft Nephropathy and Calcineurin Inhibitor Toxicity and the Adverse Effects of Sirolimus After Conversion
    Sayin, B.
    Karakayali, H.
    Colak, T.
    Sevmis, S.
    Pehlivan, S.
    Demirhan, B.
    Haberal, M.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (07) : 2789 - 2793
  • [30] The Efficacy and Limitations of Sirolimus Conversion in Liver Transplant Patients Who Develop Renal Dysfunction on Calcineurin Inhibitors
    Patrick Lam
    Atsushi Yoshida
    Kimberly Brown
    Marwan Abouljoud
    Iman Bajjoka
    Fadi Dagher
    Dilip K. Moonka
    Digestive Diseases and Sciences, 2004, 49 : 1029 - 1035
12345